Sam S. Chang MD, MBA

🚨 Inaugural program 🚨 will be held in Indianapolis July 24-26! Designed to bring together residents and current SUO fellows, attendees will receive a $500 travel stipend and coverage for hotel stay!! More info below ⬇️⬇️⬇️

The SUO is pleased to introduce FUO: Future Urologic Oncologists, an immersive, in-person educational program designed to introduce senior urology residents to the clinical, collaborative, and leadership dimensions of Urologic Oncology. Learn more here: bit.ly/4bGE0UI

FUO 2026 applications are open! Senior urology residents (PGY3 in Aug 2026) are invited to join the inaugural SUO Future Urologic Oncologists program in Indianapolis (July 24–26) for mentorship, education, and networking with leaders in urologic oncology. Apply by April 20!

Please join us in congratulating two of our very own, Craig Comiter, MD, and Ekene Enemchukwu, MD, MPH, for their recognition from the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU). Alan Wein Mentorship Award | @CraigComiter McGuire-Zimskind Award | @DrEnemchukwu Well deserved! @sufuorg @StanfordMed @jessiege_ @Belay_RE @JayOgunk @Ama_Ndumele @sherry_lu5 @julianakim04 @TommyJiang_2023 @Annie_Zwaschka @StanfordMed @liaojoe1 @geoffsonn @contisimon @DrEnemchukwu @DrBenjaminChung @DrMEisenberg @DonaldDeglover @GuolanLu @johnleppert @twiropa @ShkolyarE @isaackimjr @AmerUrological @KathleenKanMD

So well deserved Such an important role model and educator @VUMChealth @VUMCDiscoveries @VUMCurology

Five-year efficacy and tolerability data for nadofaragene firadenovec in BCG-unresponsive #BladderCancer. @AmyLuckenbaugh @VUMCurology joins @zklaassen_md @GACancerCenter to discuss nadofaragene firadenovec long-term outcomes in this conversation on UroToday > bit.ly/4so9YMX

Did you see the AUA along with @UroOnc released an amendment to the Early Detection of Prostate Cancer Guideline last week? Thank you Guideline Chair Dr. Dan Lin for talking about the important updates to this guideline. Click to read it now: bit.ly/3P2dEom

March is #KidneyCancerAwarenessMonth If you’ve followed this page for a while, you know I was diagnosed with kidney cancer in February 2024. Now, two years out, as strange as it may sound, I find myself deeply thankful for the people this journey has brought into my life, patients, caregivers, advocates, and the incredible medical teams working tirelessly behind the scenes. This year alone, nearly 85,000 people in the U.S. will hear the words “you have kidney cancer.” That number is a powerful reminder of why research, awareness, and patient advocacy matter so much. Because of continued research and the voices of patients pushing for progress, survival rates, especially for stage 4 disease, have improved significantly with the introduction of new therapies. We still have a long way to go, but there is real hope where there once was very little. I take comfort knowing there are doctors, researchers, and advocates on the front lines every day fighting for better outcomes, better treatments, and ultimately cures. In a bit of ironic timing, my own scan schedule now falls every March. A yearly reminder of how life can change in an instant and how important it is to keep moving forward anyway. Cancer is deeply personal and looks different for every person who faces it. But what unites us is the bond we share, resilience, support, and the determination to keep living fully in the midst of uncertainty. So this month, and every month, I encourage you to support research, listen to patient stories, advocate for those still fighting, and most of all, keep living your life, whatever that looks like for you. I love you all 🧡

This week's Editor's Choice! A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial by Jeremy Yuen-Chun Teoh et al Read the full article: buff.ly/Rqp3sBB We thank the authors for publishing in #euo ✍️ @uroweb @mroupret @jteoh_hk @Ric_Campi @CaPsurvivorship @UroDocAsh @LauraMarandino @RenuEapen @Ecastromarcos @OncoAlert @Sciencedirect

Appreciate the time and effort of everyone who was so welcoming at @PSH_Urology What a great team there and doing their research…

Wonderful hospitality with a great and engaged group of residents and faculty led by @urojdr. Truly enjoyed my time

Great time with our visiting professor @chadritchmd The future of Florida Urology @CleveClinicFL is bright. @ClevelandClinic @CleClinicUroRes

We are very proud of our 2012 residency alumnus @chadritchmd! The new chair of @CleClinicUro Florida!! southfloridahospitalnews.com/nationally-rec…

It was great connecting with colleagues, attending meaningful educational sessions and celebrating the work of urologic oncology at the SUO 2025 Annual Meeting in Phoenix. Thank you to everyone who joined us and helped make it such an excellent event.

@HeismanTrophy I want to vote for #DiegoPavia. ⚓️⬇️

This is really impressive @jteoh_hk especially also the presence of detrusor muscle in all specimens could indicate that we may be able to get consistent and reliable resection quality with VES #BladderCancer @EurUrolOncol @Oncodaily #ERBT

As a patient— why wouldn’t I want my surgeon to have best possible access, manipulation, and ability to remove all my tumor

@jteoh_hk @UrologyTiong @juliomayol @MariaJRibal @NakadaSteve @PabloNContreras @jdhdavis @prokarurol @EndoLuminalEndo @JamesPorterMD Exciting system and a possible significant advance

VES is a novel robotic surgical system that allows transurethral ERBT. The concentric tube design of the instrument arms allows controllable manipulation at a small diameter of ~1mm. This is extremely crucial to allow a two-handed surgery w/o obscuring the endoscopic view. (2/n)

Hot off the press!! First reported case series of transurethral robotic en bloc resection of bladder tumour using the Virtuoso Endoscopy System (VES). Published in @EurUrolOncol today! (1/n) #ERBT #UroSoMe

ERBT is only the beginning! Having a transurethral robotic system with different instruments (e.g.needle holder) allows us to explore new surgical approaches that can never be achieved b4. As a urologist, we should gear up for another exciting robotic journey in the future! (4/n)

We did 6 cases of robotic ERBT in 2 days. 100% detrusor muscle presence, 100% successful ERBT/ modified ERBT, 91% evaluable margins and clear resection margins, no grade 2 or above complications. Small number for sure but the results are indeed very promising. (3/n)